Bronchopulmonary carcinoid tumor and related cervical vertebral metastasis with PET-positive and octreotide-negative scintigraphy

Clinical Nuclear Medicine

Volumn 31, Issue 2, 2006, Pages 101-103

  Nguyen, Ba D ^a   Ram, Panol C ^a  

^a MAYO CLINIC   (United States)

Author keywords

Bone metastasis; Bronchopulmonary carcinoid tumor; Positron emission tomography; Somatostatin receptor scintigraphy; Spine

Indexed keywords

PENTETREOTIDE IN 111; SOMATOSTATIN RECEPTOR; TRACER; DIAGNOSTIC AGENT; DRUG DERIVATIVE; FLUORODEOXYGLUCOSE F 18; INDIUM 111 OCTREOTIDE; INDIUM-111-OCTREOTIDE; OCTREOTIDE; RADIOPHARMACEUTICAL AGENT;

AGED; ANAMNESIS; ARTICLE; BONE SCINTISCANNING; CASE REPORT; CERVICAL SPINE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG CARCINOMA; LUNG NODULE; MALE; NEUROENDOCRINE TUMOR; POSITRON EMISSION TOMOGRAPHY; SPINE METASTASIS; THORAX RADIOGRAPHY; BRONCHUS TUMOR; CARCINOID; INCIDENTAL FINDING; LABORATORY DIAGNOSIS; METASTASIS; SCINTISCANNING; SPINAL CORD TUMOR;

AGED; BRONCHIAL NEOPLASMS; CARCINOID TUMOR; CERVICAL VERTEBRAE; FALSE NEGATIVE REACTIONS; FLUORODEOXYGLUCOSE F18; HUMANS; INCIDENTAL FINDINGS; MALE; OCTREOTIDE; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SPINAL NEOPLASMS;

EID: 33646083257     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rlu.0000196603.90748.a0     Document Type: Article

References (8)

1. Fanti S, Farsad M, Battista G, et al. Somatostatin receptor scintigraphy for bronchial carcinoid follow-up. Clin Nucl Med. 2003;28:548-552.
2. Kwekkeboom DJ, Krenning EP. Somatostatin receptor imaging. Semin Nucl Med. 2002;32:84-91.
3. Belhocine T, Foidart J, Rigo P, et al. Fluorodeoxyglucose positron emission tomography and somatostatin receptor scintigraphy for diagnosing and staging carcinoid tumours: correlations with the pathological indexes p53 and Ki-67. Nucl Med Commun. 2002;23:727-734.
4. Scanga DR, Martin WH, Delbeke D. Value of FDG PET imaging in the management of patients with thyroid, neuroendocrine, and neural crest tumors. Clin Nucl Med. 2004;29:86-90.
5. Musi M, Carbone RG, Bertocchi C, et al. Bronchial carcinoid tumours: a study on clinicopathological features and role of octreotide scintigraphy. Lung Cancer. 1998;22:97-102.
6. Filosso PL, Ruffini E, Oliaro A, et al. Long-term survival of atypical bronchial carcinoids with liver metastases, treated with octreotide. Eur J Cardiothorac Surg. 2002;21:913-917.
7. Rodriguez JA, Meyers MO, Jacome TH, et al. Intraoperative detection of a bronchial carcinoid with a radiolabeled somatostatin analog. Chest. 2002;121:985-988.
8. Orlefors H, Sundin A, Garske U, et al. Whole-body 11C-5-hydroxytryptophan positron emission tomography as a universal imaging technique for neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and computed tomography. J Clin Endocrinol Metab. 2005;90:3392-3400.